Invivyd appoints Paul B. Bolno, M.D. to board; regains Nasdaq compliance

Invivyd, Inc.

Dr. Bolno, President and CEO of Wave Life Sciences, appointed to Board and Compensation Committee effective September 22, 2025.
He receives $40,000 annual cash retainer, $5,000 for committee service, and 100,000 stock options vesting over three years.
Christine Akinc resigned from Board and all committees on September 22; departure not due to any disagreement.
Nasdaq notified Invivyd on September 22 that it regained compliance with the $1.00 minimum bid price requirement, closing the matter.

item 5.02item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.